Camrelizumab
Clinical trials for Camrelizumab explained in plain language.
Never miss a new study
Get alerted when new Camrelizumab trials appear
Sign up with your email to follow new studies for Camrelizumab, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Two-Drug punch shrink esophageal tumors before surgery?
Disease control Recruiting nowThis phase 2 trial is testing whether adding interferon gamma to the immunotherapy drug camrelizumab, along with chemotherapy, can help shrink tumors before surgery in people with locally advanced esophageal squamous cell carcinoma. The goal is to see if this combination increase…
Matched conditions: CAMRELIZUMAB
Phase 2 • Sponsor: Hefei Cancer Hospital of the Chinese Academy of Sciences • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New combo therapy aims to fight inoperable liver cancer
Disease control Recruiting nowThis phase 3 trial is testing whether adding two drugs—camrelizumab (an immunotherapy) and apatinib (a targeted therapy)—to a standard liver cancer procedure called TACE can help people with liver cancer that cannot be removed by surgery. The study will enroll 101 participants wi…
Matched conditions: CAMRELIZUMAB
Phase 3 • Sponsor: Guohui Xu • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC